Aquestive Therapeutics: Oral Anaphylaxis NDA Opportunity Spells Buy
Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...
Seeking Alpha6d
LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript
The company encourages you to consult the risk factors contained in our SEC filings for additional detail, including in our 2024 Form 10-K ... submission of our NDA in August, and its acceptance ...